GLPG1205 shows reduction in lung volume decline over 26 weeks vs placebo when measured with novel volumetric CT analysis in IPF patients
M. Thillai (Cambridge, United Kingdom), K. Kirov (Cambridge, United Kingdom), E. Santermans (Mechelen, Belgium), M. Roberts (Cambridge, United Kingdom), P. Molyneaux (London, United Kingdom), F. Kanavati (Cambridge, United Kingdom), D. Gallagher (Cambridge, United Kingdom), A. De Haas-Amatsaleh (Mechelen, Belgium), T. Van Der Aa (Mechelen, Belgium), P. Ford (Mechelen, Belgium), C. Seemayer (Basel, Switzerland), B. Van Den Blink (Mechelen, Belgium), A. Ruggiero (Cambridge, United Kingdom)
Source: International Congress 2022 – Promising new approaches in idiopathic interstitial pneumonias
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Thillai (Cambridge, United Kingdom), K. Kirov (Cambridge, United Kingdom), E. Santermans (Mechelen, Belgium), M. Roberts (Cambridge, United Kingdom), P. Molyneaux (London, United Kingdom), F. Kanavati (Cambridge, United Kingdom), D. Gallagher (Cambridge, United Kingdom), A. De Haas-Amatsaleh (Mechelen, Belgium), T. Van Der Aa (Mechelen, Belgium), P. Ford (Mechelen, Belgium), C. Seemayer (Basel, Switzerland), B. Van Den Blink (Mechelen, Belgium), A. Ruggiero (Cambridge, United Kingdom). GLPG1205 shows reduction in lung volume decline over 26 weeks vs placebo when measured with novel volumetric CT analysis in IPF patients. 1931
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|